David Raben
Chief Medical Officer at Bicara Therapeutics Inc. (BCAX)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $1.1M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Apr 28SEC | BCAXBicara Therapeutics Inc. | Sell Plan | 5,50055,286 held (−9%) | $22.88 | $126K | -23.5% |
| Mar 26SEC | BCAXBicara Therapeutics Inc. | Sell Plan | 5,50055,286 held (−9%) | $18.95 | $104K | -7.7% |
| Mar 5SEC | BCAXBicara Therapeutics Inc. | Sell Plan | 20055,286 held (−0%) | $18.45 | $4K | -5.1% |
| Mar 5SEC | BCAXBicara Therapeutics Inc. | Sell Plan | 16,30055,286 held (−23%) | $18.52 | $302K | -5.5% |
| Nov 25SEC | BCAXBicara Therapeutics Inc. | Sell Plan | 5,50035,497 held (−13%) | $18.45 | $101K | -5.1% |
| Nov 25SEC | BCAXBicara Therapeutics Inc. | Sell Plan | 4,59435,497 held (−11%) | $18.84 | $87K | -7.1% |
| Nov 25SEC | BCAXBicara Therapeutics Inc. | Sell Plan | 90635,497 held (−2%) | $18.84 | $17K | -7.1% |
| Oct 10SEC | BCAXBicara Therapeutics Inc. | Sell Plan | 22,00035,497 held (−38%) | $18.45 | $406K | -5.1% |
- Sell
Chief Medical Officer David Raben sold $126K of BCAX at $22.88 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer David Raben sold $104K of BCAX at $18.95 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer David Raben sold $4K of BCAX at $18.45 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer David Raben sold $302K of BCAX at $18.52 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer David Raben sold $101K of BCAX at $18.45 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer David Raben sold $87K of BCAX at $18.84 — pre-scheduled 10b5-1 plan sale.